Skip to main content

Advertisement

SpringerLink
Log in

Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene

  • ORIGINAL ARTICLE
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

IL-33 is a new member of the IL-1 family that plays a role in allergic disease. In this study, we evaluated the potential on the inhibition of atopic dermatitis (AD) of anti-mouse IL-33 antibody (αIL-33Ab) using 2, 4-dinitrochlorobenzene (DNCB)-induced AD mice model. We treated mice with αIL-33Ab via subcutaneous injection of each DNCB treatment 1 h later from day 1 to day 33 for 14 times. A control group received tacrolimus. Skin lesion and scratching behavior were compared. Ear thickness, dermatitis score, eosinophils and mast cells infiltration, and serum IgE levels were also analyzed. Correlations between serum IL-33 as well as soluble(s) ST2 and AD disease activity index in human AD were also investigated. DNCB-induced AD-like mice treated with αIL-33Ab showed improved AD-like symptoms. Eosinophils and mast cells infiltration and serum IgE levels were also significantly reduced by αIL-33Ab. Our study suggests that blockade of IL-33 has a curative effect on AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Weidinger, S., and N. Novak. 2016. Atopic dermatitis. Lancet 387 (10023): 1109–1122. https://doi.org/10.1016/S0140-6736(15)00149-X.

    Article  PubMed  Google Scholar 

  2. Karuppagounder, V., S. Arumugam, R.A. Thandavarayan, V. Pitchaimani, R. Sreedhar, R. Afrin, M. Harima, H. Suzuki, M. Nomoto, S. Miyashita, K. Suzuki, M. Nakamura, K. Ueno, and K. Watanabe. 2015. Tannic acid modulates NF휅B signaling pathway and skin inflammation in NC/Nga mice through PPAR훾 expression. Cytokine 76 (2): 206–213. https://doi.org/10.1016/j.cyto.2015.05.016.

    Article  CAS  PubMed  Google Scholar 

  3. Liu, F.T., H. Goodarzi, and H.Y. Chen. 2011. IgE, mast cells, and eosinophils in atopic dermatitis. Clinical Reviews in Allergy & Immunology 41 (3): 298–310. https://doi.org/10.1007/s12016-011-8252-4.

    Article  CAS  Google Scholar 

  4. Numerof, R.P., and K. Asadullah. 2006. Cytokine and anti-cytokine therapies for psoriasis and atopic dermatitis. BioDrugs 20 (2): 93–103.

    Article  CAS  PubMed  Google Scholar 

  5. Molfino, N.A., D. Gossage, R. Kolbeck, J.M. Parker, and G.P. Geba. 2012. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clinical and Experimental Allergy 42 (5): 712–737. https://doi.org/10.1111/j.1365-2222.2011.03854.x.

    Article  CAS  PubMed  Google Scholar 

  6. Di Lernia, V. 2015. Therapeutic strategies in extrinsic atopic dermatitis: focus on inhibition of IL-4 as a new pharmacological approach. Expert Opinion on Therapeutic Targets 19 (1): 87–96. https://doi.org/10.1517/14728222.2014.965682.

    Article  PubMed  Google Scholar 

  7. Chow, J.Y., C.K. Wong, P.F. Cheung, and C.W. Lam. 2010. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cellular & Molecular Immunology 7 (1): 26–34. https://doi.org/10.1038/cmi.2009.106.

    Article  CAS  Google Scholar 

  8. Olivry, T., D. Mayhew, J.S. Paps, K.E. Linder, C. Peredo, D. Rajpal, H. Hofland, and J. Cote-Sierra. 2016. Early activation of Th2/Th22 inflammatory and pruritogenic pathways in acute canine atopic dermatitis skin lesions. The Journal of Investigative Dermatology 136 (10): 1961–1969. https://doi.org/10.1016/j.jid.2016.05.117.

    Article  CAS  PubMed  Google Scholar 

  9. Schmitz, J., A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, X. Li, D.M. Gorman, J.F. Bazan, and R.A. Kastelein. 2005. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (5): 479–490.

    Article  CAS  PubMed  Google Scholar 

  10. Liew, F.Y., N.I. Pitman, and I.B. McInnes. 2010. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nature Reviews. Immunology 10 (2): 103–110. https://doi.org/10.1038/nri2692.

    Article  CAS  PubMed  Google Scholar 

  11. Saluja, R., M.E. Ketelaar, T. Hawro, M.K. Church, M. Maurer, and M.C. Nawijn. 2015. The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Molecular Immunology 63 (1): 80–85. https://doi.org/10.1016/j.molimm.2014.06.018.

    Article  CAS  PubMed  Google Scholar 

  12. Iikura, M., H. Suto, N. Kajiwara, K. Oboki, T. Ohno, Y. Okayama, H. Saito, S.J. Galli, and S. Nakae. 2007. IL-33 can promote survival, adhesion and cytokine production in human mast cells. Laboratory Investigation 87 (10): 971–978.

    Article  CAS  PubMed  Google Scholar 

  13. Pecaric-Petkovic, T., S.A. Didichenko, S. Kaempfer, N. Spiegl, and C.A. Dahinden. 2009. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113 (7): 1526–1534. https://doi.org/10.1182/blood-2008-05-157818.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kroeger, K.M., B.M. Sullivan, and R.M. Locksley. 2009. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. Journal of Leukocyte Biology 86 (4): 769–778. https://doi.org/10.1189/jlb.0708452.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Saluja, R., A. Zoltowska, M.E. Ketelaar, and G. Nilsson. 2016. IL-33 and thymic stromal lymphopoietin in mast cell functions. European Journal of Pharmacology 778: 68–76. https://doi.org/10.1016/j.ejphar.2015.04.047.

    Article  CAS  PubMed  Google Scholar 

  16. Li, C., I. Maillet, C. Mackowiak, C. Viala, F. Di Padova, M. Li, D. Togbe, V. Quesniaux, Y. Lai, and B. Ryffel. 2017. Experimental atopic dermatitis depends on IL-33R signaling via MyD88 in dendritic cells. Cell Death & Disease 8 (4): e2735. https://doi.org/10.1038/cddis.2017.90.

    Article  CAS  Google Scholar 

  17. Mizutani, N., T. Nabe, and S. Yoshino. 2013. Interleukin-33 and alveolar macrophages contribute to the mechanisms underlying the exacerbation of IgE-mediated airway inflammation and remodelling in mice. Immunology 139 (2): 205–218. https://doi.org/10.1111/imm.12071.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Hanifin, J.M., and G. Rajka. 1980. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92 (Suppl): 44–47.

    Google Scholar 

  19. Severity scoring of atopic dermatitis: the SCORAD index. 1993. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186(1):23–31.

  20. Kilkenny, C., W. Browne, I.C. Cuthill, M. Emerson, D.G. Altman, and NC3Rs Reporting Guidelines Working Group. 2010. Animal research: reporting in vivo experiments: the ARRIVE guidelines. British Journal of Pharmacology 160 (7): 1577–1579. https://doi.org/10.1111/j.1476-5381.2010.00872.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. McGrath, J., G. Drummond, E. Mclachlan, C. Kilkenny, and C.L. Wainwright. 2010. Guidelines for reporting experiments involving animals: the ARRIVE guidelines. British Journal of Pharmacology 160 (7): 1573–1576. https://doi.org/10.1111/j.1476-5381.2010.00873.x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Kim, H., J.R. Kim, H. Kang, J. Choi, H. Yang, P. Lee, J. Kim, and K.W. Lee. 2014. 7,8,4′-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice. PLoS One 9 (8): e104938. https://doi.org/10.1371/journal.pone.0104938.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yamashita, H., T. Makino, H. Mizukami, and M. Nose. 2007. Pharmacological characterization of a chronic pruritus model induced by multiple application of 2, 4, 6-trinitrochlorobenzene in NC mice. European Journal of Pharmacology 563: 233–239.

    Article  CAS  PubMed  Google Scholar 

  24. Leung, D.Y., R.L. Hirsch, L. Schneider, C. Moody, R. Takaoka, S.H. Li, L.A. Meyerson, S.G. Mariam, G. Goldstein, and J.M. Hanifin. 1990. Thymopentin therapy reduces the clinical severity of atopic dermatitis. The Journal of Allergy and Clinical Immunology 85 (5): 927–933.

    Article  CAS  PubMed  Google Scholar 

  25. Jo, S., J. Ryu, H. Kim, M. Kim, M.H. Ryu, H. Kim, and S.I. Cho. 2015. Anti-inflammatory effects of Sanguisorbae Radix on contact dermatitis induced by dinitrofluorobenzene in mice. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-015-2148-8.

  26. Lu, Y., J.H. Yang, X. Li, K. Hwangbo, S.L. Hwang, Y. Taketomi, M. Murakami, Y.C. Chang, C.H. Kim, J.K. Son, and H.W. Chang. 2011. Emodin, a naturally occurring anthraquinone derivative, suppresses IgE-mediated anaphylactic reaction and mast cell activation. Biochemical Pharmacology 82 (11): 1700–1708. https://doi.org/10.1016/j.bcp.2011.08.022.

    Article  CAS  PubMed  Google Scholar 

  27. Brandt EB, Sivaprasad U. 2011. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol. 2(3). doi: https://doi.org/10.4172/2155-9899.1000110.

  28. Lu, Y., Y. Li, M. Jin, J.H. Yang, X. Li, G.H. Chao, H.H. Park, Y.N. Park, J.K. Son, E. Lee, and H.W. Chang. 2012. Inula japonica extract inhibits mast cell-mediated allergic reaction and mast cell activation. Journal of Ethnopharmacology 143 (1): 151–157. https://doi.org/10.1016/j.jep.2012.06.015.

    Article  CAS  PubMed  Google Scholar 

  29. Kawakami, T., T. Ando, M. Kimura, B.S. Wilson, and Y. Kawakami. 2009. Mast cells in atopic dermatitis. Current Opinion in Immunology 21 (6): 666–678. https://doi.org/10.1016/j.coi.2009.09.006.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Leung, D.Y. 2000. Atopic dermatitis: new insights and opportunities for therapeutic intervention. The Journal of Allergy and Clinical Immunology 105 (5): 860–876. https://doi.org/10.1067/mai.2000.106484.

    Article  CAS  PubMed  Google Scholar 

  31. Beck, L.A., and D.Y. Leung. 2000. Allergen sensitization through the skin induces systemic allergic responses. The Journal of Allergy and Clinical Immunology 106 (5 Suppl): S258–S263.

    Article  CAS  PubMed  Google Scholar 

  32. Tamagawa-Mineoka, R., Y. Okuzawa, K. Masuda, and N. Katoh. 2014. Increased serum levels of interleukin 33 in patients with atopic dermatitis. Journal of the American Academy of Dermatology 70 (5): 882–888. https://doi.org/10.1016/j.jaad.2014.01.867.

    Article  CAS  PubMed  Google Scholar 

  33. Savinko, T., S. Matikainen, U. Saarialho-Kere, M. Lehto, G. Wang, S. Lehtimäki, P. Karisola, T. Reunala, H. Wolff, A. Lauerma, and H. Alenius. 2012. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. The Journal of Investigative Dermatology 132 (5): 1392–1400. https://doi.org/10.1038/jid.2011.446.

    Article  CAS  PubMed  Google Scholar 

  34. Vocca, L., C. Di Sano, C.G. Uasuf, A. Sala, L. Riccobono, S. Gangemi, G.D. Albano, A. Bonanno, R. Gagliardo, and M. Profita. 2015. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology 220 (8): 954–963. https://doi.org/10.1016/j.imbio.2015.02.005.

    Article  CAS  PubMed  Google Scholar 

  35. Hamzaoui, A., A. Berraies, W. Kaabachi, M. Haifa, J. Ammar, and H. Kamel. 2013. Induced sputum levels of IL-33 and soluble ST2 in young asthmatic children. The Journal of Asthma 50 (8): 803–809. https://doi.org/10.3109/02770903.2013.816317.

    Article  CAS  PubMed  Google Scholar 

  36. Nygaard, U., M. Hvid, C. Johansen, M. Buchner, R. Fölster-Holst, M. Deleuran, and C. Vestergaard. 2016. TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 30 (11): 1930–1938. https://doi.org/10.1111/jdv.13679.

    CAS  PubMed  Google Scholar 

  37. Hayakawa, H., M. Hayakawa, A. Kume, and S. Tominaga. 2007. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. The Journal of Biological Chemistry 282: 26369–26380.

    Article  CAS  PubMed  Google Scholar 

Download references

Funding Information

This work was supported by Scientific Research General Project of Educational Department in Liaoning Province of China in 2014 (Grant No. L2014295) and Science and Technology Project of Shenyang (Grant No. 17-230-9-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Author notes

  1. Ge Peng and Zhenzhen Mu contributed equally to this work.

Authors and Affiliations

  1. Department of Dermatology, Shengjing Hospital of China Medical University, No. 36 Sanhao St., Heping Area, Shenyang, Liaoning, 110004, China

    Ge Peng, Zhenzhen Mu, Lixia Cui, Pengyue Liu, Ying Wang, Wenqing Wu & Xiuping Han

Authors
  1. Ge Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zhenzhen Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lixia Cui
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pengyue Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ying Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wenqing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiuping Han
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiuping Han.

Ethics declarations

The study adhered to the tenets of the Declaration of Helsinki. The study was approved by the local ethical committee (2016PS001K) and oral consent was obtained from all individuals.

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Suppl. 1

(DOCX 705 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, G., Mu, Z., Cui, L. et al. Anti-IL-33 Antibody Has a Therapeutic Effect in an Atopic Dermatitis Murine Model Induced by 2, 4-Dinitrochlorobenzene. Inflammation 41, 154–163 (2018). https://doi.org/10.1007/s10753-017-0673-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-017-0673-7

KEY WORDS

Search

Navigation